Whilst mitotic rat embryonic cardiomyoblast-derived H9c2 cells have been widely used as a model system to study the protective mechanisms associated with flavonoids, they are not fully differentiated cardiac cells. Hence the aim of this study was to investigate the cardioprotective and cardiotoxic actions of quercetin and two of its major in vivo metabolites, quercetin 3-glucuronide and 3'-O-methyl quercetin, using differentiated H9c2 cells. The differentiated cardiomyocyte-like phenotype was confirmed by monitoring expression of cardiac troponin 1 following 7 days of culture in reduced serum medium containing 10 nM all-trans retinoic acid. Quercetin-induced cardiotoxicity was assessed by monitoring MTT reduction, LDH release, caspase 3 activity and reactive oxygen species production following prolonged flavonoid exposure (72 h). Cardiotoxicity was observed with quercetin and 3'-O-methyl quercetin but not quercetin 3-glucuronide.
Introduction
Flavonoids are a large group of compounds (4000) that occur naturally in fruits, vegetables, nuts, seeds, flowers and other plant matter and as such they are an integral part of the human diet [1] . They all share a common three-ring structure but are subdivided into flavonols, flavons, flavanols and flavanons according to their substituents [2] . Epidemiological studies indicate that diets rich in flavonoids are associated with reduced incidences of several chronic diseases including cardiovascular disease, asthma, type II diabetes and certain types of cancer [3] . The cardioprotective properties of flavonoids are multi-faceted involving anti-oxidant, anti-hypercholesterolemia, antiinflammatory, and inhibition of platelet aggregation effects [3] . The anti-oxidant property of flavonoids was thought, until relatively recently, to underlie the majority of their protective cellular effects. However, it is becoming increasingly apparent that flavonoids also influence cellular function by modulating the activity of many enzymes including the inhibition of protein kinases and lipid kinases [1, 4] .
The inhibitory effect of flavonoids on protein kinase activity is primarily due to their ability to function as competitive inhibitors of the ATP-binding domain located in the active site of these enzymes [1, 4] . Protein kinases directly inhibited by flavonoids include protein kinase C (PKC), myosin-light chain kinase (MLCK), and MEK1 [1, 4] . MEK1
is an up-stream kinase responsible for the activation of extracellular signal-regulated kinase 1/2 (ERK1/2), a member of the mitogen-activated protein kinase (MAPK) family of protein kinases [5] . This family also includes p38 MAPK and JNK signalling pathways, both of which are targets for modulation by flavonoids [6] [7] [8] . It is also notable that flavonoids such as quercetin also inhibit (via competitive inhibition of the ATP-binding site) the lipid kinase PI-3K [9] , which plays a prominent role in the activation of protein kinase B (PKB; also known as Akt).
The MEK/ERK1/2 and the PI-3K/PKB pathways are important signalling pathways which mediate cell survival and cardioprotection against ischaemia/reperfusion injury 4 [10, 11] . In contrast, p38 MAPK and JNK cascades are typically associated with inflammation and cell death; however there is also evidence that they mediate cardioprotection [11] . Hence the cardioprotective effects of flavonoids may relate to their ability to modulate MAPK and PI-3K/PKB signalling cascades. Indeed, recent studies have shown that grape seed proanthocyanidin extract protects cardiomyocytes from ischaemia/reperfusion injury via PKB activation [12] . Similarly, quercetin (the most abundant dietary flavonoid) protected H9c2 cardiomyoblasts from H2O2-induced cell death via enhancement of ERK1/2 and PI-3K/PKB signalling [13] . In contrast, isorhamnetin (a flavonol isolated from sea buckthorn) prevented H2O2-induced activation of apoptosis in H9c2 cells through ERK1/2 inactivation [14] .
It is notable that rat embryonic cardiomyoblast-derived H9c2 cells [15] have been widely used as a model system to study the protective mechanisms associated with flavonoids [6, 7, 13, 14, 16, 17] . However, these studies have all been performed using mitotic H9c2 cardiomyoblasts, which although possessing similar morphological, electrophysiological, and biochemical properties to primary cardiomyocytes [18] are not fully differentiated cardiac cells. H9c2 cardiomyoblasts can be differentiated towards a more cardiomyocyte-like phenotype by culturing cells in reduced serum medium containing all-trans retinoic acid [19, 20] . These conditions promote the expression of cardiac specific L-type Ca 2+ channels and troponin 1 and induce the appearance of cardiomyocyte-like ultra-structural features [19, 20] .
The primary aim of this study was to investigate the cardioprotective actions of quercetin and two of its major in vivo metabolites (quercetin 3-glucuronide and 3'-O-methyl quercetin) using differentiated H9c2 cells. The ability of quercetin and its metabolites to elicit cell survival were assessed by monitoring oxidative stress-induced cell death. The potential role of MAPK (e.g. ERK1/2, p38 MAPK and JNK) and PKB signalling pathways in mediating the protective effects of quercetin were also explored. The main findings of the study indicate that quercetin protects differentiated H9c2 cardiac cells from oxidative stress induced death possibly via the inactivation of MAPK and PKB signalling.
Materials and Methods

Materials
Quercetin, quercetin 3-glucuronide, and all-trans retinoic acid were purchased from were dissolved in DMSO, which was present in all treatments including the control at a final concentration of 0.1% (v/v).
Cell culture
Rat embryonic cardiomyoblast-derived H9c2 cells were obtained from the European Collection of Animal Cell Cultures (Porton Down, Salisbury, UK). Undifferentiated cells were cultured in Dulbecco's modified Eagle's Medium (DMEM) supplemented with 2 mM Lglutamine, 10% (v/v) FBS, penicillin (100 U/ml) and streptomycin (100 g/ml). Cells were maintained in a humidified incubator (95% air/5% CO2 at 37°C) until 70-80% confluent, detached using trypsin (0.05% w/v)/EDTA (0.02% w/v) and sub-cultured (1:5 split ratio. Differentiation of H9c2 cells was induced by culturing the cells for 7 days in DMEM supplemented with 1% FBS (v/v) and 10 nM all-trans retinoic acid [19, 20] . The 6 medium was replaced every two days and differentiation into a more cardiomyocyte-like phenotype confirmed by monitoring the expression of cardiac troponin 1 by immunocytochemistry and Western blotting, as described previously [20] .
Immunocytochemistry
The in order to confirm the uniformity of protein loading.
Determination of intracellular oxidative stress
Oxidative stress was determined using 2′,7′-dichlorofluorescein diacetate (DCFDA), a reactive oxygen species (ROS) sensitive fluorescent probe (Abcam, Cambridge, UK).
Analysis of ROS production was performed using H9c2 cells differentiated for 7 days in 
Data analysis
Statistical significance was determined by ANOVA with a post hoc Dunnett's test (P<0.05 was considered statistically significant). All data are presented as means + S.E.M. The n in the text refers to the number of separate experiments.
Results
Differentiation of H9c2 cells and quercetin cardiotoxicity
Mitotic H9c2 cells derived from embryonic rat heart tissue [15] are increasingly used as an in vitro model for studies exploring cardioprotection since they display similar morphological, electrophysiological and biochemical properties to primary cardiac myocytes [18] . However, mitotic H9c2 cells can be differentiated into a more cardiomyocyte-like phenotype when cultured in DMEM supplemented with 1% FBS (v/v) and 10 nM all-trans retinoic acid [19, 20] . In this study mitotic H9c2 cells were cultured in differentiation medium for 1, 3, 7 and 9 days. As shown in Figure 1 the expression of cardiac troponin 1 increased markedly after 7 days, confirming H9c2 cell differentiation into a more cardiomyocyte-like phenotype. Hence, H9c2 cells differentiated for 7 days were used throughout the study and initial experiments investigated whether quercetin induced cardiotoxicity.
Differentiated H9c2 cells were exposed to quercetin for 24, 48 and 72 h, after which cell viability was assessed by monitoring MTT reduction and LDH release. As shown in Figure 2a and 2b, exposure to quercetin (1-100 M) for 24 h had no significant effect on cell viability. Overall, these observations indicate that quercetin-induces cardiotoxicity at a concentration (10 M) achievable in the plasma through dietary supplements or quercetinenriched foods [4] . Since MTT reduction and LDH release do not discriminate between apoptotic and necrotic forms of cell death, the effect of quercetin on caspase 3 activity (a marker of apoptotic cell death) was determined. As shown in Figure 3 , exposure to 100 M quercetin (48 h and 72 h) induced a significant increase in caspase 3 activity, suggesting that quercetin-induced apoptosis contributes to cardiotoxicity.
The cardiotoxicity of quercetin may be a consequence of its intracellular metabolism to a semiquinone and/or quinone, both of which function as pro-oxidants [21, 22] . Hence we determined whether the cardiotoxic effect of quercetin was due to its pro-oxidant properties. Levels of ROS were measured using the fluorescent probe DCFDA. As shown in Figure 4 , exposure to 100 M quercetin (48 h and 72 h) induced a significant increase in ROS, suggesting that quercetin-induced oxidative stress contributes to cardiotoxicity.
In order to understand the mechanism(s) of quercetin-induced cardiotoxicity more fully, the effect of quercetin on protein kinase cascades associated with cell survival and cell death e.g. ERK1/2, p38 MAPK, JNK and PKB was investigated. Modulation of protein kinase activity was assessed by Western blotting using phospho-specific antibodies that recognise phosphorylated motifs within activated ERK1/2 (pTEpY), p38 MAPK (pTGpY), JNK (pTPpY) and PKB (S We also investigated the cardiotoxicity of two major in vivo quercetin metabolites; 3'-Omethyl quercetin and quercetin 3-glucuronide. As shown in Figure 6 , exposure to quercetin 3-glucuronide for up 72 h had no significant on H9c2 cell viability, as judged by MTT reduction and LDH release. In contrast, 3'-O-methyl quercetin-induced cardiotoxicity was clearly evident at a concentration of 3 µM following 48 h and 72 h treatment, when assessed using MTT reduction ( Figure 7 ). However, when monitoring LDH release, 3'-O-methyl quercetin-induced cardiotoxicity was only evident at a concentration of 12
Effect of quercetin on oxidative stress-induced cell death
As outlined in the Introduction, previous studies have used mitotic H9c2 cells to explore the cardioprotective mechanisms of flavonoids [6, 7, 13, 14, 16, 17] . In this study we investigated the ability of quercetin and two of its major in vivo metabolites (quercetin of quercetin 3-glucuronide observed in this study.
Effect of quercetin on oxidative stress-induced protein kinase activation
In order to understand the mechanism(s) of quercetin-induced protection against H2O2-induced cell damage, the effect of quercetin on H2O2-induced protein kinase activation (e.g. ERK1/2, p38 MAPK, JNK and PKB) was investigated using western blotting. Previous studies have shown that reactive oxygen species, including H2O2, activate an array of intracellular signalling pathways that are associated with cell death and survival [23] . Indeed, studies have reported H2O2-induced activation of ERK1/2, p38 MAPK, JNK and PKB pathways in cardiomyocytes [24] [25] [26] . In this study, treatment of differentiated H9c2 cells with 600 µM (Figure 12b) . Similarly, these protein kinase inhibitors had no significant effect on H2O2-induced cell death (Figure 12c ). Western blot analysis using phosphospecific ERK1/2, p38 MAPK, JNK, and PKB antibodies confirmed inhibition of kinase activation by the above protein kinase inhibitors (data not shown) .
Discussion
Quercetin-induced cardiotoxicity
Initial experiments explored the potential cytotoxic effects of quercetin exposure using differentiated H9c2 cells. In agreement with previous studies, albeit using mitotic H9c2 cells [13] , 24 h exposure to quercetin (up to 100 µM) had no significant effect on the viability of differentiated H9c2 cells. However, quercetin-induced cardiotoxicity was evident following 48 h exposure with significant inhibition of MTT reduction at quercetin concentrations of 100 M and 30 M and increased LDH release at 100 M. At 72 h cardiotoxicity was evident at 10 M quercetin when assessed by the inhibition of MTT reduction. The difference in sensitivity between MTT and LDH assays is in agreement with previous studies which have reported the MTT assay as being more sensitive in detecting cytotoxic events [27] . To our knowledge this is the first report describing cardiotoxic effects of quercetin following prolonged (>48 h) exposure and importantly occurring at concentrations (10 µM) achievable in the plasma through ingestion of dietary supplements or quercetin-enriched foods [4] . These cytotoxic effects are consistent with previous studies showing that quercetin triggers or enhances drug-induced apoptosis in leukaemia cell lines [28] , human prostate cancer cells [29] and mouse cortical neurons [30] . The cytotoxic effects of quercetin may relate to its intracellular metabolism to pro-oxidative metabolites [21, 22] . In this study prolonged quercetin treatment of H9c2 cells (>48 h) resulted in the generation of ROS, which supports a role for pro-oxidative damage in the mechanism of quercetin-induced cardiotoxicity.
We also explored the potential cardiotoxicity effects of two major in vivo quercetin In neuronal cells, quercetin-induced cell death involves the inhibition of cell survival signalling pathways (PKB and ERK1/2) and activation of caspase-3 [30] . In this study quercetin (100 µM) also triggered the activation of caspase-3 following 48 h and 72 h exposure, suggesting quercetin-induced cardiotoxicity involves apoptotic cell death. In order to understand more clearly the mechanism(s) of quercetin-induced cardiotoxicity the effect of prolonged quercetin exposure on protein kinase cascades associated with cell survival (ERK1/2 and PKB) and cell death (p38 MAPK and JNK) was investigated. In view of their respective roles in cell death and cell survival, it would be predicted that quercetininduced cardiotoxicity may involve attenuation of ERK1/2 and PKB signalling and/or activation of p38 MAPK and JNK. Since the molecular actions of quercetin include inhibition of the protein kinase MEK1 and the lipid kinase PI-3K, two critical up-stream kinases involved in the activation of pro-survival ERK1/2 and PKB signalling cascades, respectively [32, 33] , pre-treatment of H9c2 cells with quercetin would be expected to attenuate levels of phosphorylated ERK1/2 and PKB. Indeed, quercetin attenuates MEK1 activity more effectively than the widely used MEK1 inhibitor PD98059 [34] . In this current study treatment with 100 µM quercetin for 24 h attenuated ERK1/2 phosphorylation. The effect of prolonged quercetin (100 µM) exposure on PKB phosphorylation revealed a biphasic response with inhibition observed following 24 h treatment, whereas later time points displayed increases in PKB phosphorylation. Previous studies have revealed conflicting data regarding the effects of quercetin on ERK1/2 and PKB signalling. For example, 24 h treatment with quercetin (30 µM) activates ERK1/2 and PKB in mitotic H9c2 cells [13] .
Activation of ERK1/2 by quercetin has also been observed in macrophages (>50 µM for 40 min; [35] ) and pancreatic β cells (20 µM for 1 h; [36] ). Finally quercetin (10 µM for 60 min) induces increases in ERK1/2, JNK, p38 MAPK and PKB phosphorylation in HepG2 cells [8] . In contrast, quercetin inhibits ERK1/2 and PKB phosphorylation in neuronal cells (30 µM up to 6 h; [30] and the anti-proliferative effect of quercetin on cancer cells is via PKB inhibition [37] . In this study, using differentiated H9c2 cells, 24 h exposure to quercetin (30 µM) had no significant effect on the basal levels of phosphorylated (active) ERK1/2, p38 MAPK, JNK or PKB. This presumably reflects the cellular metabolism of quercetin which is undetectable in mitotic H9c2 cells after 24 h exposure to 30 µM having peaked at 1 h [13] .
In contrast, 24 h exposure to 100 µM quercetin significantly reduced basal levels of phosphorylated ERK1/2 and PKB. These data are comparable to results obtained using selective up-stream inhibitors of these protein kinases, namely PD98059 (MEK1 inhibitor) and LY 294002 (PI-3K inhibitor).
In this study prolonged treatment with quercetin (100 µM for 72 h) resulted in significant increases in the levels of phosphorylated p38 MAPK and JNK in differentiated H9c2 cells.
Given the pro-apoptotic role of these kinases it is conceivable that their activation contributes to quercetin-induced cardiotoxicity. Although it is interesting to note that quercetin-induced neuronal damage appears to be independent of JNK [28] . Although it is not clear how quercetin induces an increase in JNK and p38 MAPK phosphorylation in differentiated H9c2 cells, a recent study has revealed that quercetin (100 µM; 6 h) stimulates TAK1 and MKK3/6, two upstream kinases associated with p38 MAPK activation, in macrophages [38] . Further experiments are clearly needed to explore the connection between quercetin-induced activation of p38 MAPK/JNK and cell death, possibly through the use of selective pharmacological inhibitors of these kinases, although prolonged (72 h) treatment with such inhibitors may also induce cell death. Thus, quercetin-induced cardiotoxicity potentially involves the modulation of multiple protein kinase cascades associated with cell survival (ERK1/2 and PKB) and cell death (p38 MAPK and JNK).
Although beyond the scope of the present study, future experiments will explore in more detail the concentration and time dependent effects of quercetin on these kinases and their upstream activators.
Quercetin-induced cardioprotection
In this study, we investigated the ability of quercetin and two of its major in vivo The switch from a cardioprotective to cardiotoxic action may reflect a switch from anti-oxidant to pro-oxidant effects due to the accumulation of oxidative metabolites and/or a temporal modulation of multiple kinase pathways associated with cell death and survival.
Previous studies have shown that 3'-O-methyl quercetin (up to 30 µM) protects dermal fibroblasts against H2O2-induced cell damage, whereas quercetin 7-O-β-D-glucuronide had no protective effects [21] . Similar results were obtained in the current work, although the protective effects of 3'-O-methyl quercetin were only observed at a concentration of 100 µM. The difference between the two quercetin metabolites may reflect their uptake into differentiated H9c2 cells. However, Angeloni et al. [13] reported that 3'-O-methyl quercetin did not protect mitotic H9c2 cells against oxidative damage.
Mechanisms of quercetin-induced cardioprotection
A previous report has shown that quercetin protects mitotic H9c2 cells against H2O2-induced cell death via the activation of ERK1/ 2 and PI-3K/PKB signalling pathways [13] . These data were based on the observation that pre-treatment of cells with PD98059 (MEK1 inhibitor) and LY 294002 (PI-3K inhibitor) attenuated quercetin-induced protection [13] . In this study treatment of cells with PD98059 (50 µM) and LY 294002 (30 µM) had no significant effect on 30 µM quercetin-induced protection. Similarly, inhibitors of p38 MAPK (SB203580; 30 µM) and JNK (SP 600125; 10 µM) also had no effect on quercetin-induced protection. The apparent discrepancy between this study and Angeloni et al. [13] may reflect the use of mitotic versus differentiated H9c2 cells. However, it is important to note that in this study 24 h quercetin (30 µM) pre-treatment did not activate PKB, ERK1/2, p38 MAPK or JNK and hence inhibitors of these kinases would not be expected to reverse the protective effect of quercetin.
The mechanism(s) of quercetin-induced protection against H2O2-induced cell damage may involve modulation of H2O2-induced protein kinase activation e.g. ERK1/2, PKB, p38
MAPK, and JNK, since these signalling pathways are associated with redox-mediated cell death and survival [39] . However, in the current study, inhibitors of these kinases had no significant effect on H2O2-induced cell death. Previous studies have shown H2O2-induced activation of ERK1/2, p38 MAPK, JNK and PKB pathways in cardiomyocytes [24] [25] [26] . We also observed significant activation of these kinase cascades by H2O2 (600 µM; 2 h) in differentiated H9c2 cells. Previous studies using mitotic H9c2 cells have shown that H2O2
(150 µM; 1 h) attenuated PKB phosphorylation, whereas levels of phosphorylated ERK1/2
were not modulated [13] . The disparity between the results obtained in this study and those of Angenloni et al. [13] Spencer [40] . However, it is important to note that quercetin is known to inhibit a 20 multitude of other protein kinases that include CK2, AMPK, RSK2, S6K1, IKK, Hck and 16
cell-cycle related kinases [4, 41, 42] . Although this study has shown that quercetin attenuates H2O2-induced PKB, ERK1/2, p38 MAPK and JNK activation and promotes cell survival, inhibitors of these kinases had no significant effect on H2O2-induced cell death.
The discrepancy between these observations suggests that the protective effect of quercetin may be a consequence of the simultaneous inhibition of multiple kinase pathways as opposed to the lack of protection observed with inhibitors of individual kinase pathways.
It is important to note that quercetin in foods is glycosylated and, as such, plasma levels of the aglycone are very low or undetectable [4] . However, following ingestion, quercetin glycosides are rapidly hydrolysed in the gut to quercetin aglycone, which is subsequently metabolized into glucuronidated, sulphated or methylated derivatives via phase II conjugation reactions. It has also been suggested that many of the major metabolites of quercetin exhibit weaker in vitro effects than the parent compound [43] .
The data presented is this study confirms this view, since quercetin 3-glucuronide did not elicit cardioprotection, whereas 3'-O-methyl quercetin was only effective at 100 µM.
Furthermore, recent studies have suggested that circulating quercetin glucuronides in the plasma function as quercetin carriers, which when taken up by cells are deconjugated into the more active aglycone [44] . Hence in this study it is notable that quercetin 3-glucuronide was unable to produce either cardiotoxic or cardioprotective effects, suggesting that this metabolite may not be de-conjugated in H9c2 cells.
In 
